American Shared Hospital Services vs Fulgent Genetics
AMS and FLGT side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AMS and FLGT compare
Fulgent Genetics is the larger company, worth 97 times as much as American Shared Hospital Services ($666M against $6.8M).
Fulgent Genetics grew revenue faster over the last twelve months (6.8% versus 4.0% for American Shared Hospital Services).
American Shared Hospital Services keeps more of each dollar of sales as profit, with a net margin of −5.8% compared with −26.0% at Fulgent Genetics.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AMS | FLGT |
|---|---|---|
| Size and price | ||
| Market cap | $6.8M | $666M |
| Share price | $1.03 | $24.21 |
| Change, 1 year | −53.2% | −16.8% |
| Change, 5 years | −59.9% | −75.2% |
| Beta (5Y) | 0.78 | 0.49 |
| Employees | 44 | 1,300 |
| StockData Score | ||
| Total score | 7 | 7 |
| Valuation score | 3 | 3 |
| Growth score | 1 (better) | 0 |
| Performance score | 2 (better) | 1 |
| Health score | 1 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.2× (better) | 2.1× |
| P/B | 0.3× (better) | 0.7× |
| EV/EBITDA | 10.6× | – |
| P/FCF | 1.9× | – |
| FCF yield | 51.6% (better) | −15.6% |
| Fair value | $3.02 | $45.28 |
| Margin of safety | 65.9% (better) | 46.5% |
| Growth | ||
| Revenue growth (TTM) | 4.0% | 6.8% (better) |
| Revenue growth, 5Y average | 9.5% (better) | −5.2% |
| Profitability | ||
| Gross margin | 17.1% | 35.6% (better) |
| Operating margin | −11.8% (better) | −37.7% |
| Net margin | −5.8% (better) | −26.0% |
| FCF margin | 11.6% (better) | −32.0% |
| Return on equity | −7.5% (better) | −8.0% |
| Return on invested capital | −8.7% (better) | −10.9% |
| Financial health | ||
| Debt / equity | 0.70 | 0.00 (better) |
| Net debt / EBITDA | 5.34 | – |
| Interest coverage | −2.7× (better) | −1019.0× |
| Current ratio | 0.77 | 6.34 (better) |
| Altman Z-score | 0.48 | 5.25 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Buyback yield | – | 9.6% |
| Shareholder yield | 0.00% | 9.6% (better) |
| Ownership | ||
| Held by institutions | 7.6% | 57.0% |
| Held by insiders | 38.1% | 39.5% |
| Insider net buying, 12 months | $1.3M (better) | −$286K |
| Short interest, % of float | 0.28% | 12.1% |
Go deeper
- AMS stock overview
- AMS income statement
- AMS valuation and score
- FLGT stock overview
- FLGT income statement
- FLGT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.